The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection
Abstract
To clarify the association between Campylobacter jejunei (Cj) infection and antibodies to ganglioside GM 1 (anti‐GM 1) in Guillain‐Barré syndrome (GBS), we have carried out a prospective case‐control study of 96 patients with GBS. Cj infection occurred in 25 (26%) patients. IgG and/or IgM anti‐GM 1 were identified in 24 (25%) patients and in 1 of 71 (1.4%) household controls (p < 0.001). Thirteen of the 25 (52%) Cj‐postive patients had anti‐GM 1 compared with 11 of the 71 (15%) Cj‐negative patients (p < 0.001). Neither the peak overall disability nor the 1‐year disability differed between the anti‐GM 1‐positive and anti‐GM 1‐negative patients. However, patients with the combimation of Cj infection and anti‐GM 1 positivity recovered more slowly than Cj/anti‐GM 1‐negative patients (p = 0.05), were more likely to have axonal degeneration, and were significantly more disabled at the end of 1 year (p = 0.02). The presence of Cj infection is more important than anti‐GM 1 postivity in determining the extent of axonal involvement and, hence, prognosis. Since the presence of anti‐GM 1 is not a significant poor‐prognostic factor, a search should be made for other properties of Cj infection that would account for its relationship to axonal degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessment of current diagnostic criteria for Guillain-Barr� syndrome
Asbury, A. K., & Cornblath, D. R. (1990) · Annals of Neurology · doi:10.1002/ana.410270707 · Cited by 1,905
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
Self-citationA treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
Pestronk, A., Cornblath, D. R., Ilyas, A. A., Baba, H., Quarles, R. H., Griffin, J. W., Alderson, K., & Adams, R. N. (1988) · Annals of Neurology · doi:10.1002/ana.410240113 · Cited by 609
Yuki, N., Taki, T., Inagaki, F., Kasama, T., Takahashi, M., Saito, K., Handa, S., & Miyatake, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1771 · Cited by 504
Acute axonal polyneuropathy associated with anti‐GM 1 antibodies following Campylobacter enteritis
Yuki, N., Yoshino, H., Sato, S., & Miyatake, T. (1990) · Neurology · doi:10.1212/wnl.40.12.1900 · Cited by 477
Kuroki, S., Saida, T., Nukina, M., Haruta, T., Yoshioka, M., Kobayashi, Y., & Nakanishi, H. (1993) · Annals of Neurology · doi:10.1002/ana.410330304 · Cited by 247
Guillain-Barré syndrome and Campylobacter jejuni: a serological study.
Kaldor, J., & Speed, B. R. (1984) · BMJ · doi:10.1136/bmj.288.6434.1867 · Cited by 204
N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome
Kusunoki, S., Chiba, A., Kon, K., Ando, S., Arisawa, K., Tate, A., & Kanazawa, I. (1994) · Annals of Neurology · doi:10.1002/ana.410350510 · Cited by 180
Enders, U., Karch, H., Toyka, K. V., Michels, M., Zielasek, J., Pette, M., Heesemann, J., & Hartung, H. (1993) · Annals of Neurology · doi:10.1002/ana.410340208 · Cited by 171
Ilyas, A. A., Mithen, F. A., Dalakas, M. C., Chen, Z.-W., & Cook, S. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90217-9 · Cited by 155
Cited by
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
Self-citationPeripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Campylobacter Species and Guillain-Barré Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 590
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
Hafer‐Macko, C., Hsieh, S., Ho, T. W., Sheikh, K., Cornblath, D. R., Li, C. Y., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410400414 · Cited by 512
Metadata
- Authors
- Rees, J. H., Gregson, N. A., & Hughes, R. A. C.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1995-11
- Volume
- 38
- Issue
- 5
- Pages
- 809-816
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2013153064
- Cited by
- 266
- References
- 22
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection. https://app.cochat.ai/papers/10.1002/ana.410380516
- The paper
- Rees, J. H., Gregson, N. A., & Hughes, R. A. C. (1995). Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection. Annals of Neurology. https://doi.org/10.1002/ana.410380516
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.